Market Research Logo

Global Flu Vaccine (Influenza Vaccine) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Global Flu Vaccine (Influenza Vaccine) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Scope of the Report:

This report focuses on the Flu Vaccine (Influenza Vaccine) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.

The worldwide market for Flu Vaccine (Influenza Vaccine) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

CSL

GSK

Sanofi Pasteur

Mylan

AstraZeneca

Pfizer

Johnson & Johnson

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Whole Virus Vaccines

Split Virus Vaccines

Subunit Vaccines

Live Attenuated Virus Vaccines

Market Segment by Applications, can be divided into

For Children (6 months to 3 years)

For Adults and Children over 3 years

There are 15 Chapters to deeply display the global Flu Vaccine (Influenza Vaccine) market.

Chapter 1, to describe Flu Vaccine (Influenza Vaccine) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Flu Vaccine (Influenza Vaccine), with sales, revenue, and price of Flu Vaccine (Influenza Vaccine), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Flu Vaccine (Influenza Vaccine), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Flu Vaccine (Influenza Vaccine) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Flu Vaccine (Influenza Vaccine) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


1 Market Overview
1.1 Flu Vaccine (Influenza Vaccine) Introduction
1.2 Market Analysis by Type
1.2.1 Whole Virus Vaccines
1.2.2 Split Virus Vaccines
1.2.3 Subunit Vaccines
1.2.4 Live Attenuated Virus Vaccines
1.3 Market Analysis by Applications
1.3.1 For Children (6 months to 3 years)
1.3.2 For Adults and Children over 3 years
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL
2.1.1 Business Overview
2.1.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CSL Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GSK
2.2.1 Business Overview
2.2.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi Pasteur
2.3.1 Business Overview
2.3.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mylan Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Flu Vaccine (Influenza Vaccine) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Flu Vaccine (Influenza Vaccine) Manufacturer Market Share in 2017
3.3.2 Top 6 Flu Vaccine (Influenza Vaccine) Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Flu Vaccine (Influenza Vaccine) Market Analysis by Regions
4.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Regions
4.1.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Regions (2013-2018)
4.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Regions (2013-2018)
4.2 North America Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
4.3 Europe Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
4.5 South America Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
5 North America Flu Vaccine (Influenza Vaccine) by Countries
5.1 North America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Countries
5.1.1 North America Flu Vaccine (Influenza Vaccine) Sales and Market Share by Countries (2013-2018)
5.1.2 North America Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Countries (2013-2018)
5.2 United States Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
5.3 Canada Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
5.4 Mexico Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
6 Europe Flu Vaccine (Influenza Vaccine) by Countries
6.1 Europe Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Countries
6.1.1 Europe Flu Vaccine (Influenza Vaccine) Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Countries (2013-2018)
6.2 Germany Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
6.3 UK Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
6.4 France Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
6.5 Russia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
6.6 Italy Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
7 Asia-Pacific Flu Vaccine (Influenza Vaccine) by Countries
7.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Flu Vaccine (Influenza Vaccine) Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Countries (2013-2018)
7.2 China Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
7.3 Japan Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
7.4 Korea Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
7.5 India Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
8 South America Flu Vaccine (Influenza Vaccine) by Countries
8.1 South America Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Countries
8.1.1 South America Flu Vaccine (Influenza Vaccine) Sales and Market Share by Countries (2013-2018)
8.1.2 South America Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
8.3 Argentina Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
8.4 Colombia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
9 Middle East and Africa Flu Vaccine (Influenza Vaccine) by Countries
9.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
9.3 UAE Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
9.4 Egypt Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
9.5 Nigeria Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
9.6 South Africa Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2018)
10 Global Flu Vaccine (Influenza Vaccine) Market Segment by Type
10.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Flu Vaccine (Influenza Vaccine) Sales and Market Share by Type (2013-2018)
10.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Type (2013-2018)
10.2 Whole Virus Vaccines Sales Growth and Price
10.2.1 Global Whole Virus Vaccines Sales Growth (2013-2018)
10.2.2 Global Whole Virus Vaccines Price (2013-2018)
10.3 Split Virus Vaccines Sales Growth and Price
10.3.1 Global Split Virus Vaccines Sales Growth (2013-2018)
10.3.2 Global Split Virus Vaccines Price (2013-2018)
10.4 Subunit Vaccines Sales Growth and Price
10.4.1 Global Subunit Vaccines Sales Growth (2013-2018)
10.4.2 Global Subunit Vaccines Price (2013-2018)
10.5 Live Attenuated Virus Vaccines Sales Growth and Price
10.5.1 Global Live Attenuated Virus Vaccines Sales Growth (2013-2018)
10.5.2 Global Live Attenuated Virus Vaccines Price (2013-2018)
11 Global Flu Vaccine (Influenza Vaccine) Market Segment by Application
11.1 Global Flu Vaccine (Influenza Vaccine) Sales Market Share by Application (2013-2018)
11.2 For Children (6 months to 3 years) Sales Growth (2013-2018)
11.3 For Adults and Children over 3 years Sales Growth (2013-2018)
12 Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
12.1 Global Flu Vaccine (Influenza Vaccine) Sales, Revenue and Growth Rate (2018-2023)
12.2 Flu Vaccine (Influenza Vaccine) Market Forecast by Regions (2018-2023)
12.2.1 North America Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
12.2.2 Europe Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
12.2.4 South America Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Flu Vaccine (Influenza Vaccine) Market Forecast (2018-2023)
12.3 Flu Vaccine (Influenza Vaccine) Market Forecast by Type (2018-2023)
12.3.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Type (2018-2023)
12.3.2 Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Type (2018-2023)
12.4 Flu Vaccine (Influenza Vaccine) Market Forecast by Application (2018-2023)
12.4.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Application (2018-2023)
12.4.2 Global Flu Vaccine (Influenza Vaccine) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report